BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia

Infections represent a cause of morbidity and mortality in patients affected by chronic lymphocytic leukemia (CLL). Introduction of new drugs in CLL clinical practice has showed impressive efficacy, in particular those targeting BTK. Among the consistent clinical data, an increasing number of report...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorcari, Stefania, Maffei, Rossana, Vallerini, Daniela, Scarfò, Lydia, Barozzi, Patrizia, Maccaferri, Monica, Potenza, Leonardo, Ghia, Paolo, Luppi, Mario, Marasca, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485008/
https://www.ncbi.nlm.nih.gov/pubmed/32983178
http://dx.doi.org/10.3389/fimmu.2020.02158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485008/
https://www.ncbi.nlm.nih.gov/pubmed/32983178
http://dx.doi.org/10.3389/fimmu.2020.02158

Ejemplares similares